SEC Form 4 · accession 0001193125-26-296590
Sight Sciences, Inc. · SGHT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alison Bauerlein
Officer — Chief Operating Officer
Period of report
Jul 2, 2026
Accepted (ET)
Jul 6, 2026 · 7:32 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001531177
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2,F3 | Jul 2, 2026 | S | 24,184 | $5.36 | D | 664,709 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Reflects shares of the Issuer's common stock, par value $0.001 per share ("Common Stock"), sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units ("RSUs").
- F2Reflects the weighted average price at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $5.19 to $5.46, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F3Includes (i) 192,669 shares of Common Stock, and (ii) 472,040 shares of Common Stock which shall be acquired upon the vesting and settlement of RSUs that have not yet vested.